CD133 mRNA may be a suitable prognostic marker for human breast cancer
Stem Cell Investigation Nov 16, 2017
Xia P - The Gene Expression-Based Outcome for Breast Cancer Online algorithm (GOBO) software to analyses the prognostic roles of CD133 mRNA in the subtypes of breast cancer. It was shown that for human breast cancer, CD133 mRNA could be a suitable prognostic marker.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
